Alon Harris Selected Research

Timolol (Blocadren)

1/2013	The effect of nebulized dorzolamide/timolol fixed combination mist versus drops on retrobulbar blood flow and intraocular pressure in glaucoma patients.
3/2012	Comparison of intraocular pressure, blood pressure, ocular perfusion pressure and blood flow fluctuations during dorzolamide versus timolol add-on therapy in prostaglandin analogue treated glaucoma subjects.
1/2012	Short-term effects of brimonidine/timolol and dorzolamide/timolol on ocular perfusion pressure and blood flow in glaucoma.
1/2011	Evaluation of hemodynamic parameters as predictors of glaucoma progression.
4/2010	Update and critical appraisal of combined timolol and carbonic anhydrase inhibitors and the effect on ocular blood flow in glaucoma patients.
2/2010	Ocular blood flow and oxygen delivery to the retina in primary open-angle glaucoma patients: the addition of dorzolamide to timolol monotherapy.
9/2009	Visual function, optic nerve structure, and ocular blood flow parameters after 1 year of glaucoma treatment with fixed combinations.
10/2006	A comparative analysis of the effects of the fixed combination of timolol and dorzolamide versus latanoprost plus timolol on ocular hemodynamics and visual function in patients with primary open-angle glaucoma.
10/2003	Evaluation of retinal haemodynamics and retinal function after application of dorzolamide, timolol and latanoprost in newly diagnosed open-angle glaucoma patients.
3/2002	Effects of timolol and dorzolamide on retrobulbar hemodynamics in patients with newly diagnosed primary open-angle glaucoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alon Harris Research Topics

Disease

39	Glaucoma 12/2022 - 04/2002
36	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2022 - 03/2002
11	Macular Degeneration (Age-Related Maculopathy) 01/2022 - 02/2002
7	Macular Edema 12/2022 - 12/2007
5	Retinal Vein Occlusion 12/2022 - 03/2010
3	Cataract (Cataracts) 01/2022 - 10/2018
3	Choroidal Neovascularization 01/2022 - 10/2003
3	Disease Progression 01/2020 - 10/2003
3	Diabetic Retinopathy (Retinopathy, Diabetic) 10/2019 - 12/2007
2	Ganglion Cysts (Ganglion) 01/2022 - 01/2021
2	Migraine Disorders (Migraine) 01/2022 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 07/2006
2	Eye Diseases (Eye Disease) 10/2019 - 10/2008
2	Inflammation (Inflammations) 10/2019 - 05/2010
2	Retinal Diseases 10/2019 - 01/2017
2	Hypertension (High Blood Pressure) 12/2017 - 09/2013
2	Ocular Hypertension (Glaucoma, Suspect) 01/2017 - 10/2016
2	Histoplasmosis 11/2009 - 10/2003
1	Tics (Tic) 12/2022
1	Optic Nerve Diseases (Optic Neuropathy) 01/2022
1	Wet Macular Degeneration 01/2022
1	Blindness (Hysterical Blindness) 01/2022
1	Ischemia 01/2022
1	Cutaneous Malignant Melanoma 05/2021
1	Neoplasms (Cancer) 05/2021
1	Normal Pressure Hydrocephalus 03/2021
1	Traumatic Brain Injuries (Traumatic Brain Injury) 09/2020
1	Sleep Wake Disorders 02/2020
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2020
1	Pain (Aches) 10/2019
1	Geographic Atrophy 10/2018
1	Exfoliation Syndrome 03/2016
1	Calculi (Calculus) 01/2016
1	Arthrogryposis renal dysfunction cholestasis syndrome 01/2016
1	Diabetes Mellitus 07/2014
1	Overweight 09/2013
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 03/2012

Drug/Important Bio-Agent (IBA)

33	Retinaldehyde (Retinal)IBA 09/2022 - 02/2002
12	dorzolamide (Trusopt)FDA LinkGeneric 01/2013 - 03/2002
10	Timolol (Blocadren)FDA LinkGeneric 01/2013 - 03/2002
6	Latanoprost (Xalatan)FDA Link 12/2022 - 10/2003
6	Oxygen (Dioxygen)IBA 01/2022 - 10/2008
6	Bevacizumab (Avastin)FDA Link 11/2018 - 11/2009
5	Biomarkers (Surrogate Marker)IBA 12/2022 - 09/2020
4	Triamcinolone (Aristocort)FDA Link 11/2018 - 10/2003
4	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 07/2016 - 10/2003
3	Bimatoprost (Lumigan)FDA Link 12/2022 - 10/2010
3	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 07/2006
3	4-(2-oxapentadeca-4-yne)phenylpropanoic acidIBA 09/2013 - 03/2012
2	Carbonic Anhydrase InhibitorsIBA 10/2022 - 04/2010
2	Synthetic Prostaglandins (Prostaglandin Analogues)IBA 10/2022 - 03/2012
2	Pharmaceutical PreparationsIBA 10/2022 - 10/2019
2	SteroidsIBA 01/2022 - 03/2012
2	TESIBA 01/2022 - 10/2018
2	Antiglaucoma AgentsIBA 06/2021 - 11/2003
2	ElementsIBA 03/2021 - 01/2016
2	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2019 - 12/2018
2	Dexamethasone (Maxidex)FDA LinkGeneric 11/2018 - 05/2014
2	Transforming Growth Factors (Transforming Growth Factor)IBA 04/2017 - 06/2013
2	propan-2-yl 4- (6- (4- (2,5- difluorophenoxy)- 3- hydroxybut- 1- en- 1- yl)- 7- hydroxyoctahydro- 2H- cyclopenta(b)oxepin- 3- yl)butanoateIBA 01/2017 - 10/2016
2	Antiphospholipid AntibodiesIBA 03/2016 - 06/2015
1	AcidsIBA 12/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Vascular Endothelial Growth Factor DIBA 01/2022
1	Vascular Endothelial Growth Factor CIBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	SaltsIBA 01/2022
1	IntegrinsIBA 01/2022
1	CTLA-4 AntigenIBA 05/2021
1	Monoclonal AntibodiesIBA 05/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2021
1	MelatoninIBA 02/2020
1	LipidsIBA 01/2020
1	AKB-9778IBA 10/2019
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2019
1	bromfenac FDA Link 10/2019
1	AngiopoietinsIBA 10/2019
1	AntioxidantsIBA 03/2018
1	Ranibizumab (Lucentis)FDA Link 07/2016
1	Phosmet (Prolate)IBA 01/2016
1	Fluocinolone Acetonide (Capex)FDA LinkGeneric 05/2014
1	GlucocorticoidsIBA 05/2014
1	Liposomes (Liposome)IBA 04/2014
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 09/2013
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2013
1	DiureticsIBA 09/2013
1	Angiotensin Receptor AntagonistsIBA 09/2013
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2012
1	Brimonidine Tartrate (Alphagan)FDA LinkGeneric 01/2012

Therapy/Procedure

12	Therapeutics 12/2022 - 10/2002
5	Lasers (Laser) 10/2019 - 05/2007
3	Trabeculectomy (Trabeculoplasty) 10/2019 - 11/2009
2	Precision Medicine 08/2021 - 10/2019
2	Filtering Surgery 10/2019 - 11/2009
2	Ambulatory Care (Outpatient Care) 05/2013 - 08/2011
2	Intravitreal Injections 03/2012 - 11/2009
1	Immunotherapy 05/2021
1	Ventriculoperitoneal Shunt 03/2021
1	Drug Therapy (Chemotherapy) 01/2020
1	Light Coagulation 07/2016